How do we measure the costs, benefits, and harms of sharing data from biomedical studies? A protocol for a scoping review

Introduction: The benefits of sharing participant-level data, including clinical or epidemiological data, genomic data, high-dimensional imaging data, or human-derived samples, from biomedical studies have been widely touted and may be taken for granted. As investments in data sharing and reuse effo... View More